Balyasny Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-871,409
| Closed | -$5.24M | – | 2917 |
|
|
2022
Q4 | $5.24M | Buy |
+871,409
| New | +$5.24M | 0.01% | 744 |
|
|
2022
Q3 | – | Sell |
-102,333
| Closed | -$611K | – | 2953 |
|
|
2022
Q2 | $611K | Buy |
102,333
+58,197
| +132% | +$347K | ﹤0.01% | 1520 |
|
|
2022
Q1 | $206K | Buy |
+44,136
| New | +$206K | ﹤0.01% | 1660 |
|
|
2019
Q2 | – | Sell |
-218,273
| Closed | -$212K | – | 1679 |
|
|
2019
Q1 | $212K | Sell |
218,273
-704,382
| -76% | -$684K | ﹤0.01% | 1243 |
|
|
2018
Q4 | $677K | Buy |
922,655
+622,655
| +208% | +$457K | ﹤0.01% | 919 |
|
|
2018
Q3 | $648K | Sell |
300,000
-12,916
| -4% | -$27.9K | ﹤0.01% | 1083 |
|
|
2018
Q2 | $1.56M | Buy |
+312,916
| New | +$1.56M | 0.01% | 843 |
|